Primara supplies peptide therapies and GLP-1 / GLP-2 compounds to verified B2B partners across the US, Latin America, and the Caribbean — every lot GMP-manufactured and COA-verified.

Every compound ships with lot-level documentation and storage guidance built into the label system.

Semaglutide, Tirzepatide, Retatrutide, Liraglutide, Teduglutide.

BPC-157, Ipamorelin, CJC-1295 — lyophilized, reconstitution-ready.

Lyophilized powder, liquid vials, and oral formulations.
Quality is the product. Primara treats documentation, testing, and chain-of-custody as core deliverables — not afterthoughts.
Produced under Good Manufacturing Practice conditions in the USA, with documented process controls.
Identity, HPLC purity (≥ 99%), and endotoxin results documented and available before dispatch.
Unique PHS-LOT / PHS-COA references tie every vial to its manufacturing and testing record.
Storage and handling conditions recorded from manufacture through delivery.

Domestic distribution with full regulatory documentation and rapid fulfillment.
Bilingual labeling and compliance support across LATAM markets.
Reliable cold-chain logistics to Caribbean clinical and wholesale partners.